microRNAs deregulation in head and neck squamous cell carcinoma (Q101410380)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33159410%20AND%20SRC:MED&resulttype=core&format=json

8 November 2020

title

microRNAs deregulation in head and neck squamous cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33159410%20AND%20SRC:MED&resulttype=core&format=json

head and neck squamous cell carcinoma

8 November 2020

main subject

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33159410%20AND%20SRC:MED&resulttype=core&format=json

8 November 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33159410%20AND%20SRC:MED&resulttype=core&format=json

8 November 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33159410%20AND%20SRC:MED&resulttype=core&format=json

8 November 2020

Caroline Torricelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33159410%20AND%20SRC:MED&resulttype=core&format=json

8 November 2020

Janet K Silva

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33159410%20AND%20SRC:MED&resulttype=core&format=json

8 November 2020

Gabriela S R Queiroz

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33159410%20AND%20SRC:MED&resulttype=core&format=json

8 November 2020

Manoela M Ortega

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33159410%20AND%20SRC:MED&resulttype=core&format=json

8 November 2020

publication date

6 November 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33159410%20AND%20SRC:MED&resulttype=core&format=json

8 November 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33159410%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

8 November 2020

cites work

1 reference

7 January 2021

Alcohol and head and neck cancer

1 reference

7 January 2021

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).

1 reference

7 January 2021

Current treatment of head and neck squamous cell cancer

1 reference

7 January 2021

Update of assessment of survival in head and neck cancer after regional recurrence

1 reference

7 January 2021

Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical Trial

1 reference

7 January 2021

Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer

1 reference

7 January 2021

Unraveling the molecular genetics of head and neck cancer through genome-wide approaches

1 reference

7 January 2021

Meta-analysis of microRNAs expression in head and neck cancer: uncovering association with outcome and mechanisms

1 reference

7 January 2021

MicroRNAs: target recognition and regulatory functions

1 reference

7 January 2021

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

7 January 2021

MicroRNAs in metabolism and metabolic disorders

1 reference

7 January 2021

Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants

1 reference

7 January 2021

Micro-ribonucleic acids in head and neck cancer: an introduction

1 reference

7 January 2021

Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study.

1 reference

7 January 2021

Expanding the Transcriptome of Head and Neck Squamous Cell Carcinoma Through Novel MicroRNA Discovery

1 reference

7 January 2021

Extracellular miRNAs as Biomarkers of Head and Neck Cancer Progression and Metastasis

1 reference

7 January 2021

Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer.

1 reference

7 January 2021

Clusterin is a gene-specific target of microRNA-21 in head and neck squamous cell carcinoma

1 reference

7 January 2021

MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor

1 reference

7 January 2021

miR-21 downregulates the tumor suppressor P12 CDK2AP1 and stimulates cell proliferation and invasion

1 reference

7 January 2021

TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness

1 reference

7 January 2021

MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.

1 reference

7 January 2021

MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma

1 reference

7 January 2021

miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma.

1 reference

7 January 2021

MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway

1 reference

7 January 2021

MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours.

1 reference

7 January 2021

miR-203 downregulates Yes-1 and suppresses oncogenic activity in human oral cancer cells

1 reference

7 January 2021

MicroRNA-203 Induces Apoptosis by Targeting Bmi-1 in YD-38 Oral Cancer Cells

1 reference

7 January 2021

microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer

1 reference

7 January 2021

MicroRNA-203 inhibits tumour growth and metastasis through PDPN.

1 reference

7 January 2021

Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma

1 reference

7 January 2021

Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.

1 reference

7 January 2021

MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway

1 reference

7 January 2021

miR-375 suppresses IGF1R expression and contributes to inhibition of cell progression in laryngeal squamous cell carcinoma

1 reference

7 January 2021

Regulation of multidrug resistance by microRNAs in anti-cancer therapy

1 reference

7 January 2021

MicroRNA-24 induces cisplatin resistance by targeting PTEN in human tongue squamous cell carcinoma.

1 reference

7 January 2021

Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma

1 reference

7 January 2021

miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells

1 reference

7 January 2021

Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential

1 reference

7 January 2021

miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer

1 reference

7 January 2021

miR-936 Suppresses Cell Proliferation, Invasion, and Drug Resistance of Laryngeal Squamous Cell Carcinoma and Targets GPR78

1 reference

7 January 2021

MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel‐induced multidrug resistance

1 reference

7 January 2021

MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo

1 reference

7 January 2021

MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at high-risk for cancer-specific mortality

1 reference

7 January 2021

Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis

1 reference

7 January 2021

miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer

1 reference

7 January 2021

Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study

1 reference

7 January 2021

Alcohol-dysregulated miR-30a and miR-934 in head and neck squamous cell carcinoma

1 reference

7 January 2021

A comprehensive study of smoking-specific microRNA alterations in head and neck squamous cell carcinoma

1 reference

7 January 2021

Cigarette smoke and chewing tobacco alter expression of different sets of miRNAs in oral keratinocytes.

1 reference

7 January 2021

Altered Expression of miRNAs Is Related to Larynx Cancer TNM Stage and Patients' Smoking Status

1 reference

7 January 2021

Smoking-induced control of miR-133a-3p alters the expression of EGFR and HuR in HPV-infected oropharyngeal cancer

1 reference

7 January 2021

Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers

1 reference

7 January 2021

A genome-wide comparison of the functional properties of rare and common genetic variants in humans

1 reference

7 January 2021

Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx

1 reference

7 January 2021

A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck

1 reference

7 January 2021

A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer

1 reference

7 January 2021

A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck

1 reference

7 January 2021

A miR-151 binding site polymorphism in the 3'-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma

1 reference

7 January 2021

Polymorphisms of CD44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population

1 reference

7 January 2021

Genome-scale identification of microRNA-related SNPs associated with risk of head and neck squamous cell carcinoma.

1 reference

7 January 2021

Polymorphisms of microRNA-binding sites in integrin genes are associated with oral squamous cell carcinoma susceptibility and progression

1 reference

7 January 2021

A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma

1 reference

7 January 2021

Genetic variants in let-7/Lin28 modulate the risk of oral cavity cancer in a Chinese Han population.

1 reference

7 January 2021

A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer

1 reference

7 January 2021

Association between miRNA-binding site polymorphisms in double-strand break repair genes and risk of recurrence in patients with squamous cell carcinomas of the non-oropharynx

1 reference

7 January 2021

1 reference

7 January 2021

A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers

1 reference

7 January 2021

Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis

1 reference

7 January 2021

A let-7 microRNA polymorphism in the KRAS 3'-UTR is prognostic in oropharyngeal cancer

1 reference

7 January 2021

A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer

1 reference

7 January 2021

Single-nucleotide polymorphisms among microRNA: big effects on cancer

1 reference

7 January 2021

Genetic variations in key microRNA processing genes and risk of head and neck cancer: a case-control study in Chinese population

1 reference

7 January 2021

Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies

1 reference

7 January 2021

MiR-146a rs2910164 polymorphism and head and neck carcinoma risk: a meta-analysis based on 10 case-control studies

1 reference

7 January 2021

Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma

1 reference

7 January 2021

Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck

1 reference

7 January 2021

A comprehensive evaluation for polymorphisms in family in cancer risk and prognosis: a system review and meta-analysis

1 reference

7 January 2021

The variant of pri-mir-26a-1 polymorphism is associated with decreased risk of betel quid-related oral premalignant lesions and oral squamous cell carcinoma.

1 reference

7 January 2021

MicroRNA-101 polymorphisms and risk of head and neck squamous cell carcinoma in a Chinese population

1 reference

7 January 2021

Association between polymorphisms in pre-miRNA genes and risk of oral squamous cell cancer in a Chinese population

1 reference

7 January 2021

The association between miR-499a polymorphism and oral squamous cell carcinoma progression

1 reference

7 January 2021

Single nucleotide polymorphism rs11614913 associated with CC genotype in miR-196a2 is overrepresented in laryngeal squamous cell carcinoma, but not salivary gland tumors in Polish population

1 reference

7 January 2021

Association of Polymorphic Variants of miRNA Processing Genes with Larynx Cancer Risk in a Polish Population

1 reference

7 January 2021

Evaluation of polymorphisms in microRNA biosynthesis genes and risk of laryngeal cancer in the Polish population

1 reference

7 January 2021

A sequence polymorphism in miR-608 predicts recurrence after radiotherapy for nasopharyngeal carcinoma

1 reference

7 January 2021

Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy

1 reference

7 January 2021

Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx

1 reference

7 January 2021

1 reference

7 January 2021

Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine

1 reference

7 January 2021

The Promise of MicroRNA Replacement Therapy

1 reference

7 January 2021

microRNA Therapeutics in Cancer - An Emerging Concept

1 reference

7 January 2021

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

1 reference

7 January 2021

The let-7 microRNA reduces tumor growth in mouse models of lung cancer

1 reference

7 January 2021

Regression of murine lung tumors by the let-7 microRNA

1 reference

7 January 2021

Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.

1 reference

7 January 2021

Sequence-specific inhibition of small RNA function

1 reference

7 January 2021

Silencing of microRNAs in vivo with 'antagomirs'

1 reference

7 January 2021

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

1 reference

7 January 2021

RNAi therapeutics: principles, prospects and challenges

1 reference

7 January 2021

A comparative study on nonviral genetic modifications in cord blood and bone marrow mesenchymal stem cells.

1 reference

7 January 2021

An overview of viral and nonviral delivery systems for microRNA.

1 reference

7 January 2021

The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice

1 reference

7 January 2021

In vivo delivery of miRNAs for cancer therapy: challenges and strategies.

1 reference

7 January 2021

Treatment of HCV infection by targeting microRNA

1 reference

7 January 2021

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.

1 reference

7 January 2021

Combination therapy to checkmate Glioblastoma: clinical challenges and advances

1 reference

7 January 2021

Developing therapeutic microRNAs for cancer

1 reference

7 January 2021

Exploiting Nanotechnology for the Development of MicroRNA-Based Cancer Therapeutics

1 reference

7 January 2021

Enhanced miR-9 promotes laryngocarcinoma cell survival via down-regulating PTEN.

1 reference

7 January 2021

Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma

1 reference

7 January 2021

MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.

1 reference

7 January 2021

Silencing of miR-17-5p suppresses cell proliferation and promotes cell apoptosis by directly targeting PIK3R1 in laryngeal squamous cell carcinoma

1 reference

7 January 2021

MicroRNA expression in head and neck cancer associates with alcohol consumption and survival

1 reference

7 January 2021

MicroRNA alterations in head and neck squamous cell carcinoma.

1 reference

7 January 2021

Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma

1 reference

7 January 2021

miR-21, miR-106b and miR-375 as novel potential biomarkers for laryngeal squamous cell carcinoma.

1 reference

7 January 2021

Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes

1 reference

7 January 2021

High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis

1 reference

7 January 2021

Upregulation of microRNA-23a regulates proliferation and apoptosis by targeting APAF-1 in laryngeal carcinoma

1 reference

7 January 2021

miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis

1 reference

7 January 2021

MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma

1 reference

7 January 2021

miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7.

1 reference

7 January 2021

Loss of PTEN Expression Is Associated With High MicroRNA 24 Level and Poor Prognosis in Patients With Tongue Squamous Cell Carcinoma

1 reference

7 January 2021

miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma.

1 reference

7 January 2021

miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma

1 reference

7 January 2021

Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma

1 reference

7 January 2021

Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma

1 reference

7 January 2021

Oncogenic microRNAs as biomarkers of oral tumorigenesis and minimal residual disease.

1 reference

7 January 2021

miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression

1 reference

7 January 2021

MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells

1 reference

7 January 2021

miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma

1 reference

7 January 2021

Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3.

1 reference

7 January 2021

Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2

1 reference

7 January 2021

Upregulation of a potential prognostic biomarker, miR-155, enhances cell proliferation in patients with oral squamous cell carcinoma

1 reference

7 January 2021

Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue

1 reference

7 January 2021

miR-196a overexpression and miR-196a2 gene polymorphism are prognostic predictors of oral carcinomas

1 reference

7 January 2021

OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway

1 reference

7 January 2021

miR-196b is a prognostic factor of human laryngeal squamous cell carcinoma and promotes tumor progression by targeting SOCS2

1 reference

7 January 2021

The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas

1 reference

7 January 2021

hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer

1 reference

7 January 2021

miR-211 promotes the progression of head and neck carcinomas by targeting TGFβRII.

1 reference

7 January 2021

MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity

1 reference

7 January 2021

miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma

1 reference

7 January 2021

Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma

1 reference

7 January 2021

MicroRNA‑214 promotes proliferation and inhibits apoptosis via targeting Bax in nasopharyngeal carcinoma cells

1 reference

7 January 2021

miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells

1 reference

7 January 2021

miR-222 regulates the cell biological behavior of oral squamous cell carcinoma by targeting PUMA.

1 reference

7 January 2021

Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma

1 reference

7 January 2021

Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma.

1 reference

7 January 2021

Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC

1 reference

7 January 2021

IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma

1 reference

7 January 2021

miR-424-5p Promotes Proliferation, Migration and Invasion of Laryngeal Squamous Cell Carcinoma

1 reference

7 January 2021

Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset

1 reference

7 January 2021

miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma

1 reference

7 January 2021

miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells

1 reference

7 January 2021

Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients

1 reference

7 January 2021

Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma

1 reference

7 January 2021

MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2

1 reference

7 January 2021

miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein

1 reference

7 January 2021

MicroRNA-24 inhibits growth, induces apoptosis, and reverses radioresistance in laryngeal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein.

1 reference

7 January 2021

MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.

1 reference

7 January 2021

MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2

1 reference

7 January 2021

Inhibition of integrin β1-mediated oncogenic signalling by the antitumor microRNA-29 family in head and neck squamous cell carcinoma

1 reference

7 January 2021

CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway

1 reference

7 January 2021

miR-30e-5p represses angiogenesis and metastasis by directly targeting AEG-1 in squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer

1 reference

7 January 2021

Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis

1 reference

7 January 2021

Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma

1 reference

7 January 2021

MiR-99a exerts anti-metastasis through inhibiting myotubularin-related protein 3 expression in oral cancer

1 reference

7 January 2021

MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer

1 reference

7 January 2021

MicroRNA-101 regulates autophagy, proliferation and apoptosis via targeting EZH2 in laryngeal squamous cell carcinoma

1 reference

7 January 2021

MicroRNA-107 inhibits proliferation and invasion of laryngeal squamous cell carcinoma cells by targeting CACNA2D1 in vitro

1 reference

7 January 2021

miR-125b suppresses oral oncogenicity by targeting the anti-oxidative gene PRXL2A

1 reference

7 January 2021

Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer

1 reference

7 January 2021

Downregulation of Microrna-126 Contributes to Tumorigenesis of Squamous Tongue Cell Carcinoma via Targeting KRAS.

1 reference

7 January 2021

Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling

1 reference

7 January 2021

MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion

1 reference

7 January 2021

MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines

1 reference

7 January 2021

Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma

1 reference

7 January 2021

Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics

1 reference

7 January 2021

miR-140-5p targeted FGF9 and inhibited the cell growth of laryngeal squamous cell carcinoma

1 reference

7 January 2021

MicroRNA-141 suppresses growth and metastatic potential of head and neck squamous cell carcinoma

1 reference

7 January 2021

Micro-ribonucleic acid 143 (MiR-143) inhibits oral squamous cell carcinoma (OSCC) cell migration and invasion by downregulation of phospho-c-Met through targeting CD44 v3.

1 reference

7 January 2021

Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling.

1 reference

7 January 2021

Functions of microRNA-143 in the apoptosis, invasion and migration of nasopharyngeal carcinoma

1 reference

7 January 2021

MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression.

1 reference

7 January 2021

Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.

1 reference

7 January 2021

Expression and clinical significance of microRNA-152 in supragalottic laryngeal carcinoma

1 reference

7 January 2021

MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells

1 reference

7 January 2021

MicroRNA‑152 inhibits cell proliferation, migration and invasion by directly targeting MAFB in nasopharyngeal carcinoma

1 reference

7 January 2021

Prognostic implications of micoRNA miR-195 expression in human tongue squamous cell carcinoma

1 reference

7 January 2021

MicroRNA‑195 inhibits cell proliferation, migration and invasion in laryngeal squamous cell carcinoma by targeting ROCK1.

1 reference

7 January 2021

Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma

1 reference

7 January 2021

The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma

1 reference

7 January 2021

MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma

1 reference

7 January 2021

Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma

1 reference

7 January 2021

MicroRNAs MiR-218, MiR-125b, and Let-7g predict prognosis in patients with oral cavity squamous cell carcinoma

1 reference

7 January 2021

miR-324-3p suppresses migration and invasion by targeting WNT2B in nasopharyngeal carcinoma

1 reference

7 January 2021

Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin

1 reference

7 January 2021

MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer

1 reference

7 January 2021

MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma

1 reference

7 January 2021

MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1

1 reference

7 January 2021

miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC).

1 reference

7 January 2021

miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis

1 reference

7 January 2021

miR-491-5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma

1 reference

7 January 2021

Retracted: MiR-506 Suppresses Tumor Proliferation and Invasion by Targeting FOXQ1 in Nasopharyngeal Carcinoma

1 reference

7 January 2021

miR-519 suppresses nasopharyngeal carcinoma cell proliferation by targeting oncogene URG4/URGCP.

1 reference

7 January 2021

MicroRNA-625 inhibits cell invasion and epithelial-mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma

1 reference

7 January 2021

MiR-638 suppresses the progression of oral squamous cell carcinoma through wnt/β-catenin pathway by targeting phospholipase D1

1 reference

7 January 2021

miR-639 regulates transforming growth factor beta-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting FOXC1.

1 reference

7 January 2021

Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma

1 reference

7 January 2021

MiR-4282 inhibits tumor progression through down-regulation of ZBTB2 by targeting LIN28B in oral squamous cell carcinoma

1 reference

7 January 2021

The let-7 family of microRNAs suppresses immune evasion in head and neck squamous cell carcinoma by promoting PD-L1 degradation

1 reference

7 January 2021

Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells

1 reference

7 January 2021

Integrative approach detected association between genetic variants of microRNA binding sites of TLRs pathway genes and OSCC susceptibility in Chinese Han population

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.26533

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33159410%20AND%20SRC:MED&resulttype=core&format=json

8 November 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33159410%20AND%20SRC:MED&resulttype=core&format=json